Author: Kumari G. Lokugamage; Adam Hage; Craig Schindewolf; Ricardo Rajsbaum; Vineet D. Menachery
Title: SARS-CoV-2 is sensitive to type I interferon pretreatment Document date: 2020_3_9
ID: 2w0zr9c0_6
Snippet: In the wake of the outbreak, major research efforts have sought to rapidly characterize 40 the novel CoV to aid in treatment and control. Initial modeling studies predicted (6) and 41 subsequent cell culture studies confirmed that spike protein of SARS-CoV-2 utilizes human 42 angiotensin converting enzyme 2 (ACE2) for entry, the same receptor as 8) . 43.....
Document: In the wake of the outbreak, major research efforts have sought to rapidly characterize 40 the novel CoV to aid in treatment and control. Initial modeling studies predicted (6) and 41 subsequent cell culture studies confirmed that spike protein of SARS-CoV-2 utilizes human 42 angiotensin converting enzyme 2 (ACE2) for entry, the same receptor as 8) . 43
Search related documents:
Co phrase search for related documents- cell culture and modeling study: 1, 2, 3
- cell culture and novel cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- cell culture and research effort: 1, 2, 3, 4
- cell culture and SARS spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- cell culture and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cell culture study and modeling study: 1
- cell culture study and novel cov: 1, 2, 3, 4
- cell culture study and research effort: 1
- cell culture study and SARS spike protein: 1, 2
- cell culture study and spike protein: 1, 2, 3
- control treatment and modeling study: 1, 2, 3, 4
- control treatment and novel cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- control treatment and outbreak wake: 1, 2
- control treatment and research effort: 1
- control treatment and SARS spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9
- control treatment and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- initial modeling study and modeling study: 1, 2
- major research effort and research effort: 1, 2, 3
- modeling study and novel cov: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date